|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen WQ, Zuo TT, Zheng RS, Zeng HM, Zhang
SW and He J: Lung cancer incidence and mortality in China in 2013.
Zhonghua Zhong Liu Za Zhi. 39:795–800. 2017.(In Chinese; Abstract
Available In Chinese From The Publisher). PubMed/NCBI
|
|
3
|
Yu X, Li J, Zhong X and He J: Combination
of Iodine-125 brachytherapy and chemotherapy for locally recurrent
stage III non-small cell lung cancer after concurrent
chemoradiotherapy. BMC Cancer. 15:6562015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Collins LG, Haines C, Perkel R and Enck
RE: Lung cancer: Diagnosis and management. Am Fam Physician.
75:56–63. 2007.PubMed/NCBI
|
|
5
|
Song J, Fan X, Zhao Z, Chen M, Chen W, Wu
F, Zhang D, Chen L, Tu J and Ji J: 125I brachytherapy of
locally advanced non-small-cell lung cancer after one cycle of
first-line chemotherapy: A comparison with best supportive care.
Onco Targets Ther. 10:1345–1352. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin Z, Du Y, Li Z, Jiang Y, Chen J and Liu
Y: Endoscopic ultrasonography-guided interstitial implantation of
iodine 125-seeds combined with chemotherapy in the treatment of
unresectable pancreatic carcinoma: A prospective pilot study.
Endoscopy. 40:314–320. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin J, Yang W, Jiang N, Zheng Q, Huang J,
Huang N, Li A and Jiang H: Incidence and prediction of seed
migration to the chest after iodine-125 brachytherapy for
hepatocellular carcinoma. Brachytherapy. 16:1252–1256. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tong L, Liu P, Huo B, Guo Z and Ni H:
CT-guided 125I interstitial brachytherapy for pelvic
recurrent cervical carcinoma after radiotherapy. Onco Targets Ther.
10:4081–4088. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li W, Dan G, Jiang J, Zheng Y, Zheng X and
Deng D: Repeated iodine-125 seed implantations combined with
external beam radiotherapy for the treatment of locally recurrent
or metastatic stage III/IV non-small cell lung cancer: A
retrospective study. Radiat Oncol. 11:1192016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang W, Li J, Li R, Zhang Y, Han M and Ma
W: Efficacy and safety of iodine-125 radioactive seeds
brachytherapy for advanced non-small cell lung cancer-A
meta-analysis. Brachytherapy. 17:439–448. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Özcan MF, Altınova S and Atan A: Treatment
approaches to small renal masses in patients of advanced age (≥75
years). Turk J Urol. 44:281–286. 2018.PubMed/NCBI
|
|
12
|
Di Maio M and Perrone F: Quality of life
in elderly patients with cancer. Health Qual Life Outcomes.
1:442003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Verma V, Simone CB II and Werner-Wasik M:
Acute and late toxicities of concurrent chemoradiotherapy for
locally-advanced non-small cell lung cancer. Cancers (Basel).
9:E1202017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goode KM, Nabb S, Cleland JG and Clark AL:
A comparison of patient and physician-rated New York Heart
Association class in a community-based heart failure clinic. J Card
Fail. 14:379–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stewart A, Parashar B, Patel M, O'Farrell
D, Biagioli M, Devlin P and Mutyala S: American brachytherapy
society consensus guidelines for thoracic brachytherapy for lung
cancer. Brachytherapy. 15:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cox JD, Stetz J and Pajak TF: Toxicity
criteria of the radiation therapy oncology group (RTOG) and the
European organization for research and treatment of cancer (EORTC).
Int J Radiat Oncol Biol Phys. 31:1341–1346. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aras M, Erdil TY, Dane F, Gungor S, Ones
T, Dede F, Inanir S and Turoglu HT: Comparison of WHO, RECIST 1.1,
EORTC, and PERCIST criteria in the evaluation of treatment response
in malignant solid tumors. Nucl Med Commun. 37:9–15.
2016.PubMed/NCBI
|
|
18
|
Rosenzweig KE, Fox JL, Yorke E, Amols H,
Jackson A, Rusch V, Kris MG, Ling CC and Leibel SA: Results of a
phase I dose-escalation study using three-dimensional conformal
radiotherapy in the treatment of inoperable nonsmall cell lung
carcinoma. Cancer. 103:2118–2127. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuan S, Sun X, Li M, Yu J, Ren R, Yu Y, Li
J, Liu X, Wang R, Li B, et al: A randomized study of involved-field
irradiation versus elective nodal irradiation in combination with
concurrent chemotherapy for inoperable stage III nonsmall cell lung
cancer. Am J Clin Oncol. 30:239–244. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bradley JD, Paulus R, Komaki R, Masters G,
Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A,
et al: Standard-dose versus high-dose conformal radiotherapy with
concurrent and consolidation carboplatin plus paclitaxel with or
without cetuximab for patients with stage IIIA or IIIB
non-small-cell lung cancer (RTOG 0617): A randomised, two-by-two
factorial phase 3 study. Lancet Oncol. 16:187–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Zhou Z, Liang J, Feng Q, Xiao Z,
Hui Z, Wang X, Lv J, Chen D, Zhang H, et al: Intensity-Modulated
radiation therapy may improve local-regional tumor control for
locally advanced non-small cell lung cancer compared with
three-dimensional conformal radiation therapy. Oncologist.
21:1530–1537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma L, Men Y, Feng L, Kang J, Sun X, Yuan
M, Jiang W and Hui Z: A current review of dose-escalated
radiotherapy in locally advanced non-small cell lung cancer. Radiol
Oncol. 53:6–14. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kong FM, Zhao J, Wang J and Faivre-Finn C:
Radiation dose effect in locally advanced non-small cell lung
cancer. J Thorac Dis. 6:336–347. 2014.PubMed/NCBI
|
|
24
|
Zhao J, Yorke ED, Li L, Kavanagh BD, Li
XA, Das S, Miften M, Rimner A, Campbell J, Xue J, et al: Simple
factors associated with radiation-induced lung toxicity after
stereotactic body radiation therapy of the thorax: A pooled
analysis of 88 studies. Int J Radiat Oncol Biol Phys. 95:1357–1366.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma JT, Liu Y, Sun L, Milano MT, Zhang SL,
Huang LT, Jing W, Zhao JZ, Han CB and Kong FS: Chest wall toxicity
after stereotactic body radiation therapy: A pooled analysis of 57
studies. Int J Radiat Oncol Biol Phys. 103:843–850. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maki S, Itoh Y, Kubota S, Okada T,
Nakahara R, Ito J, Kawamura M, Naganawa S, Yoshino Y, Fujita T, et
al: Clinical outcomes of 125I brachytherapy with and without
external-beam radiation therapy for localized prostate cancer:
Results from 300 patients at a single institution in Japan. J
Radiat Res. 58:870–880. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang ZM, Lu J, Liu T, Chen KM, Huang G and
Liu FJ: CT-guided interstitial brachytherapy of inoperable
non-small cell lung cancer. Lung Cancer. 74:253–257. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen HH, Jia RF, Yu L, Zhao MJ, Shao CL
and Cheng WY: Bystander effects induced by continuous low-dose-rate
125I seeds potentiate the killing action of irradiation on human
lung cancer cells in vitro. Int J Radiat Oncol Biol Phys.
72:1560–1566. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Loft SM and Dale RG: The incorporation of
specific tissue/nuclide attenuation data into the Anderson method
for producing brachytherapy volume-dose histograms. Phys Med Biol.
35:1519–1531. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang FJ, Li CX, Wu PH, Wu YX, Jiao DC,
Liu J and Li YL: CT guided radioactive 125I seed implantation in
treating localized advanced pulmonary carcinoma. Zhonghua Yi Xue Za
Zhi. 87:3272–3275. 2007.(In Chinese). PubMed/NCBI
|
|
31
|
Li J, Yu M, Xiao Y, Yang L, Zhang J, Ray E
and Yang X: Computed tomography fluoroscopy-guided percutaneous
125I seed implantation for safe, effective and real-time
monitoring radiotherapy of inoperable stage T1-3N0M0 non-small-cell
lung cancer. Mol Clin Oncol. 1:1019–1024. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li W, Guan J, Yang L, Zheng X, Yu Y and
Jiang J: Iodine-125 brachytherapy improved overall survival of
patients with inoperable stage III/IV non-small cell lung cancer
versus the conventional radiotherapy. Med Oncol. 32:3952015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Matzkin H, Chen J, German L and Mabjeesh
NJ: Comparison between preoperative and real-time intraoperative
planning 125I permanent prostate brachytherapy:
Long-term clinical biochemical outcome. Radiat Oncol. 8:2882013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen Y, Jiang Y, Ji Z, Jiang P, Xu F,
Zhang Y, Guo F, Peng R, Li X, Sun H, et al: Efficacy and safety of
CT-guided 125I seed implantation as a salvage treatment
for locally recurrent head and neck soft tissue sarcoma after
surgery and external beam radiotherapy: A 12-year study at a single
institution. Brachytherapy. 19:81–89. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang L, Zhang H, Wang Z, Zhao J, Yu H and
Wang J: The advantages of intraoperative TPS real-time planning in
treating retroperitoneal metastatic carcinoma with 125I seed
brachytherapy. J Intervent Radiol. 26:1011–1014. 2017.
|
|
36
|
Yeow KM, Su IH, Pan KT, Tsay PK, Lui KW,
Cheung YC and Chou AS: Risk factors of pneumothorax and bleeding:
Multivariate analysis of 660 CT-guided coaxial cutting needle lung
biopsies. Chest. 126:748–754. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang J, Zhang HT and Yu HM: The
significance of dynamic dose verification in radioactive (125)I
seeds implantation treatment technology. Zhonghua Yi Xue Za Zhi.
98:1810–1812. 2018.(In Chinese). PubMed/NCBI
|
|
38
|
Blair HF, Porter A and Chen QS: In vivo
detection of an 125I seed located in the intracardiac region after
prostate permanent brachytherapy. Int J Radiat Oncol Biol Phys.
58:888–891. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu AX, Wallner KE, Frivold GP, Ferry D,
Jutzy KR and Foster GP: Prostate brachytherapy seed migration to
the right coronary artery associated with an acute myocardial
infarction. Brachytherapy. 5:262–265. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ji Z, Jiang Y, Guo F, Peng R, Sun H, Wang
P, Fan J and Wang J: Radiation-related adverse effects of CT-guided
implantation of 125I seeds for thoracic recurrent and/or
metastatic malignancy. Sci Rep. 9:148032019. View Article : Google Scholar : PubMed/NCBI
|
